Vancomycin Serum Concentrations in Pediatric Oncology Patients Under Intensive Care
NCT ID: NCT01304459
Last Updated: 2012-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses
NCT04170231
Recent Techniques for Diagnosing Central Venous Catheter-related Bloodstream Infections in Children
NCT01249976
Venous Disease in Pediatric Population
NCT04424095
Ultrasound Use for Difficult Lumbar Punctures in Pediatric Oncology Patients
NCT01643291
Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
NCT05770622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients under vancomycin treatment
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grupo de Apoio ao Adolescente e a Crianca com Cancer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GLAUCIA TORIBIO FINOTI SEIXAS
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Grupo de Apoio ao Adolescente e à Criança com Câncer
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1913/10
Identifier Type: OTHER
Identifier Source: secondary_id
UTI/IOP 01/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.